About the journal
Psoriasis: Targets and Therapy is an open-access journal published by Dove Medical Press in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 3,565 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Dove Medical Press
- ISSN
- 2230-326X
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,565 USD
- Articles in DOAJ
- 209
- Declared review time
- 16 weeks
- Declared peer-review model
- other
- Official website
- https://www.dovepress.com/psoriasis-targets-and-therapy-journal
Index listings
- DOAJ · 2012-11-28
- Indexing
- DOAJ
- APC
- 3,565 USD
- Declared review time (DOAJ)
- 16 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
209
Most recent article
last month
Average review time (journal-declared via DOAJ)
16weeks
Works in OpenAlex
220
Last recorded publication year
2026
h-index
34
i10-index
86
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2012-11-28
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 75%
- ORCID iDs in current deposits
- 85%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Psoriasis, targets and therapyJournal of psoriasis
- Source type
- journal
- NLM unique ID (PubMed)
- 101709086
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Psoriasis: Treatment and Pathogenesis
- Psoriasis: Treatment and Pathogenesis
- Psoriasis: Treatment and Pathogenesis
- Dermatology and Skin Diseases
- Spondyloarthritis Studies and Treatments
- Spondyloarthritis Studies and Treatments
- Spondyloarthritis Studies and Treatments
- Dermatology and Skin Diseases
Show all subjects (75)
- Dermatology and Skin Diseases
- Rheumatoid Arthritis Research and Therapies
- Autoimmune Bullous Skin Diseases
- Autoimmune Bullous Skin Diseases
- Rheumatoid Arthritis Research and Therapies
- Skin Diseases and Diabetes
- Skin Diseases and Diabetes
- Biological Research and Disease Studies
- Biological Research and Disease Studies
- Pharmaceutical studies and practices
- Pharmaceutical studies and practices
- Cytokine Signaling Pathways and Interactions
- Rheumatoid Arthritis Research and Therapies
- Cytokine Signaling Pathways and Interactions
- Skin Protection and Aging
- Skin Protection and Aging
- Autoimmune and Inflammatory Disorders Research
- Autoimmune and Inflammatory Disorders Research
- Asthma and respiratory diseases
- Asthma and respiratory diseases
- Skin and Cellular Biology Research
- Skin and Cellular Biology Research
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Health Systems, Economic Evaluations, Quality of Life
- Genetic Associations and Epidemiology
- Health Systems, Economic Evaluations, Quality of Life
- Bioinformatics and Genomic Networks
- Bioinformatics and Genomic Networks
- Nail Diseases and Treatments
- Urticaria and Related Conditions
- Therapeutic Uses of Natural Elements
- Health Systems, Economic Evaluations, Quality of Life
- Nail Diseases and Treatments
- Urticaria and Related Conditions
- Cutaneous lymphoproliferative disorders research
- Liver Disease Diagnosis and Treatment
- Advancements in Transdermal Drug Delivery
- Therapeutic Uses of Natural Elements
- Drug-Induced Adverse Reactions
- Hidradenitis Suppurativa and Treatments
- Drug-Induced Adverse Reactions
- Hidradenitis Suppurativa and Treatments
- Osteomyelitis and Bone Disorders Research
- Skin Diseases and Diabetes
- Medication Adherence and Compliance
- Drug-Induced Adverse Reactions
- Vitamin D Research Studies
- Immunodeficiency and Autoimmune Disorders
- Vitamin D Research Studies
- Immunodeficiency and Autoimmune Disorders
- Genetic and rare skin diseases.
- Systemic Lupus Erythematosus Research
- Liver Disease Diagnosis and Treatment
- Dermatological and COVID-19 studies
- Liver Disease Diagnosis and Treatment
- Hair Growth and Disorders
- Herpesvirus Infections and Treatments
- Adipokines, Inflammation, and Metabolic Diseases
- Biosimilars and Bioanalytical Methods
- Systemic Lupus Erythematosus Research
- Skin and Cellular Biology Research
- Lipoproteins and Cardiovascular Health
- Gut microbiota and health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Smoking Behavior and Cessation
- Vitamin D Research Studies
Keywords (DOAJ)
- skin diseases
- psoriasis
- psoriatic arthritis
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ